This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07689/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07689/identifier/pubchem-compound/
n10http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB07689/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07689/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07689
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n10:DB07689 n13:DB07689
dcterms:title
METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE
adms:identifier
n7:DVP n8:25243853 n11:DB07689 n12:99444160
n4:IUPAC-Name
n5:271B5CE9-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B5CEF-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B5CEE-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B5CEB-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B5CEC-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B5CED-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B5CE7-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B5CE5-363D-11E5-9242-09173F13E4C5 n5:271B5CE8-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B5CE6-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B5CF5-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B5CF6-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B5CF0-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B5CF1-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B5CF3-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B5CF2-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B5CF4-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B5CFB-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B5CFD-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B5CFE-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B5CFA-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B5CF9-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B5CFC-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B5CEA-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B5CF7-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B5CF8-363D-11E5-9242-09173F13E4C5